These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17459056)

  • 1. BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line.
    Kawasaki T; Yokoi S; Tsuda H; Izumi H; Kozaki K; Aida S; Ozeki Y; Yoshizawa Y; Imoto I; Inazawa J
    Cancer Sci; 2007 Jul; 98(7):1070-7. PubMed ID: 17459056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.
    Yokoi S; Yasui K; Iizasa T; Imoto I; Fujisawa T; Inazawa J
    Clin Cancer Res; 2003 Oct; 9(13):4705-13. PubMed ID: 14581340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.
    Begum A; Imoto I; Kozaki K; Tsuda H; Suzuki E; Amagasa T; Inazawa J
    Cancer Sci; 2009 Oct; 100(10):1908-16. PubMed ID: 19594544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis.
    Mei YP; Liao JP; Shen J; Yu L; Liu BL; Liu L; Li RY; Ji L; Dorsey SG; Jiang ZR; Katz RL; Wang JY; Jiang F
    Oncogene; 2012 May; 31(22):2794-804. PubMed ID: 21986946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
    Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
    Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
    Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
    Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target.
    Gallegos Ruiz MI; Floor K; Roepman P; Rodriguez JA; Meijer GA; Mooi WJ; Jassem E; Niklinski J; Muley T; van Zandwijk N; Smit EF; Beebe K; Neckers L; Ylstra B; Giaccone G
    PLoS One; 2008 Mar; 3(3):e0001722. PubMed ID: 18320023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
    Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
    Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes.
    Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J
    Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer.
    Castillo SD; Angulo B; Suarez-Gauthier A; Melchor L; Medina PP; Sanchez-Verde L; Torres-Lanzas J; Pita G; Benitez J; Sanchez-Cespedes M
    J Pathol; 2010 Sep; 222(1):89-98. PubMed ID: 20556744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplification DNA in a human lung carcinoma cell line.
    Taguchi T; Cheng GZ; Bell DW; Balsara B; Liu Z; Siegfried JM; Testa JR
    Genes Chromosomes Cancer; 1997 Oct; 20(2):208-12. PubMed ID: 9331573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon.
    Eijdems EW; De Haas M; Coco-Martin JM; Ottenheim CP; Zaman GJ; Dauwerse HG; Breuning MH; Twentyman PR; Borst P; Baas F
    Int J Cancer; 1995 Mar; 60(5):676-84. PubMed ID: 7860142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
    Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
    Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.
    Kubo T; Yamamoto H; Lockwood WW; Valencia I; Soh J; Peyton M; Jida M; Otani H; Fujii T; Ouchida M; Takigawa N; Kiura K; Shimizu K; Date H; Minna JD; Varella-Garcia M; Lam WL; Gazdar AF; Toyooka S
    Int J Cancer; 2009 Apr; 124(8):1778-84. PubMed ID: 19117057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.
    Kim YH; Kwei KA; Girard L; Salari K; Kao J; Pacyna-Gengelbach M; Wang P; Hernandez-Boussard T; Gazdar AF; Petersen I; Minna JD; Pollack JR
    Oncogene; 2010 Mar; 29(10):1421-30. PubMed ID: 19966867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.
    Imoto I; Yang ZQ; Pimkhaokham A; Tsuda H; Shimada Y; Imamura M; Ohki M; Inazawa J
    Cancer Res; 2001 Sep; 61(18):6629-34. PubMed ID: 11559525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 19q13-ERCC1 gene copy number increase in non--small-cell lung cancer.
    Vanhecke E; Valent A; Tang X; Vielh P; Friboulet L; Tang T; Goubar A; Li Y; Robin A; Behrens C; Commo F; Validire P; André F; Wistuba II; Soria JC; Olaussen KA
    Clin Lung Cancer; 2013 Sep; 14(5):549-57. PubMed ID: 23773262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of chromosomal segment 4q12 in non-small cell lung cancer.
    Ramos AH; Dutt A; Mermel C; Perner S; Cho J; Lafargue CJ; Johnson LA; Stiedl AC; Tanaka KE; Bass AJ; Barretina J; Weir BA; Beroukhim R; Thomas RK; Minna JD; Chirieac LR; Lindeman NI; Giordano T; Beer DG; Wagner P; Wistuba II; Rubin MA; Meyerson M
    Cancer Biol Ther; 2009 Nov; 8(21):2042-50. PubMed ID: 19755855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.